OR WAIT null SECS
May 10, 2023
EMA and European regulators are lifting their COVID-19 business continuity measures as the pandemic’s peak ends.
May 03, 2023
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
May 02, 2023
Strike action is impacting numerous sectors across Europe, including the bio/pharma industry.
April 18, 2023
AbbVie’s RINVOQ has received European Commission approval for the treatment of moderately to severely active Crohn’s disease.
April 14, 2023
The construction will expand Catalent’s clinical supply facility in Schorndorf, Germany.
April 07, 2023
NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.
April 05, 2023
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.
April 02, 2023
A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.
March 30, 2023
CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.
March 23, 2023
Three new awards have been added to the roster for 2023 and include some specific highlights that have occurred over the past few years.